Skadden is representing Pfizer Inc in its acquisition of Ferrosan’s consumer health care business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited. Terms of the deal, announced February 7, were not disclosed. Based in Copenhagen, Ferrosan sells products primarily in the Nordic region and the emerging markets of Russia and Central and Eastern Europe.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates